Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Year range
1.
preprints.org; 2024.
Preprint in English | PREPRINT-PREPRINTS.ORG | ID: ppzbmed-10.20944.preprints202402.0500.v1

ABSTRACT

Various vaccines have been developed in response to the SARS-CoV-2 pandemic, and the safety of vaccines has become an important issue. COVID-19 vaccines-related central nervous system inflammatory demyelinating diseases (CNS IDDs) have been reported recently. We present one case of AstraZeneca vaccine-related myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease and literature review another 78 patients published from January 2020 to October 2022. Patients were divided into three vaccine groups (viral vector, mRNA and inactivated vaccines) for further analyses. Among 79 patients with COVID-19 vaccines-related CNS IDDs, 49 (62%) cases received viral vector vaccines, 20 (25.3%) received mRNA vaccines and 10 (12.7%) received inactivated vaccines. Twenty-seven cases (34.2%) were confirmed with autoantibodies, including 15 patients (19%) with anti-MOG, 11 (13.9%) with anti-aquaporin 4 (AQP4), and one (1.3%) with both antibodies. Significantly, more males developed CNS IDDs post viral vector vaccines compared to mRNA and inactivated vaccines. Patients receiving mRNA vaccines were older than other groups. Furthermore, mRNA and inactivated vaccines correlated more with anti-AQP4 antibodies, while viral vector vaccines showed higher MOG positivity. The research suggests potential associations between COVID-19 vaccines-related CNS IDDs and gender, age, and autoantibodies, contingent on vaccine types. Protein sequence analysis implies similarities between the S protein and AQP4/MOG. Further studies may elucidate the mechanisms of CNS IDDs, aiding vaccine selection for specific groups.


Subject(s)
COVID-19 , Demyelinating Diseases
2.
Atmospheric Pollution Research ; : 101498, 2022.
Article in English | ScienceDirect | ID: covidwho-1914160

ABSTRACT

China is the largest emitter of greenhouse gases in the world. However, the atmospheric observation of greenhouse gases is relatively sparse. In this study, surface measurements of CH4 over 5 years at a typical city site (Hangzhou) in an economically developed region in China were conducted to study the temporal variations and the influence of meteorological factors and airmass transport. The CH4 observations from a suburban site (Lin'an station [LAN]) which is a World Meteorological Organization/Global Atmosphere Monitoring Program (WMO/GAW) regional site, were also compared. Our results showed that the atmospheric CH4 mole fraction in Hangzhou was not only affected by meteorological factors and topography, but also by strong local emissions. Although the distance between the two stations was only 50 km, there was a significant difference in the temporal CH4 variations. The strong anthropogenic emissions in the city were responsible for the urban-suburban site difference. The CH4 peaks in the diurnal cycles in Hangzhou corresponded to rush hours, and there were unique variations during special periods (i.e., the National Day holiday, coronavirus disease 2019 [COVID - 19] lock-down). It also led to an annual average CH4 mole fraction at the Hangzhou station (HZ) that was on average 111.1 ± 1.6 ppb higher than that at the LAN from 2016 to 2020. The lock-down measures caused by the outbreak of COVID - 19 decreased the atmospheric CH4 mole fractions by 6.8% in Hangzhou but only 1.9% in Lin'an in 2020 compared to those in 2019. Excluding the data in 2020, the annual growth rate of the CH4 mole fraction was 19.0 ppb yr−1 in Hangzhou. Our results indicated that the CH4 mole fraction in Hangzhou was mainly driven by local anthropogenic emissions, although they were influenced by emissions from surrounding cities such as Nanjing and Ningbo.

SELECTION OF CITATIONS
SEARCH DETAIL